Cyclacel Pharmaceuticals Inc (CYCC)
0.39
-0.06
(-14.29%)
USD |
NASDAQ |
Nov 14, 16:00
0.39
0.00 (0.00%)
After-Hours: 16:45
Cyclacel Pharmaceuticals Profit Margin (Quarterly): -81.42K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -81.42K% |
| March 31, 2024 | -10.16K% |
| December 31, 2023 | -17.00K% |
| September 30, 2023 | -37.70K% |
| June 30, 2023 | -1.46K% |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -1.35K% |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -1.02K% |
| September 30, 2016 | -1.44K% |
| June 30, 2016 | -1.34K% |
| March 31, 2016 | -2.19K% |
| December 31, 2015 | -801.4% |
| September 30, 2015 | -378.9% |
| June 30, 2015 | -1.13K% |
| March 31, 2015 | -959.4% |
| December 31, 2014 | -1.94K% |
| September 30, 2014 | -667.6% |
| June 30, 2014 | -1.35K% |
| March 31, 2014 | -1.23K% |
| December 31, 2013 | -1.19K% |
| September 30, 2013 | -1.62K% |
| June 30, 2013 | |
| March 31, 2013 | -1.45K% |
| December 31, 2012 | -95.28K% |
| September 30, 2012 | -4.97K% |
| June 30, 2012 | -13.76K% |
| March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-81.42K%
Minimum
Jun 2024
-1.46K%
Maximum
Jun 2023
-29.55K%
Average
-17.00K%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -656.8% |
| Return on Assets | -168.0% |
| Return on Invested Capital | -656.8% |
| Operating Margin (Quarterly) | -91.10K% |
| Return on Net Operating Assets | -521.0% |